GB virus C infection in fulminant and acute hepatitis

International Hepatology Communications

Volumn 6, Issue 1, 1996, Pages 24-28

  Michitaka, Kojiro ^a   Horiike, Norio ^a   Masumoto, Toshikazu ^a   Akbar, Fazle S M ^a   Ohno, Naofumi ^b   Onji, Morikazu ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE   (Japan)

Author keywords

fulminant hepatitis; GBV C; non A hepatitis; non B hepatitis; non C hepatitis

Indexed keywords

ACUTE HEPATITIS; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HEPATITIS; HEPATITIS A VIRUS; HEPATITIS B VIRUS; HEPATITIS VIRUS; HUMAN; LIVER FAILURE; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCREENING;

EID: 0030297708     PISSN: 09284346     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-4346(96)00322-2     Document Type: Article

References (13)

1. [1] Mutimer D, Shaw J, Neuberger J, et al. Failure to incriminate hepatitis B, hepatitis C and hepatitis E viruses in the aetiology of fulminant non-A non-B hepatitis. Gut 1995; 36: 433-436.
2. [2] Deinhardt F, Holmes AW, Capps RB, et al. Studies on the transmission of disease of human viral hepatitis to marmoset monkeys. I. Transmission of disease, serial passage and description of liver lesions. J Exp Med 1967; 125: 673-687.
3. [3] Simons JN, Pilot-Matias TJ, Leary TP, et al. Identification of two flavivirus-like genomes in the GB hepatitis agent. Proc Natl Acad Sci USA 1995; 92: 3401-3405.
4. [4] Muerhoff AS, Leary TP, Simons JN et al. Genomic organization of GB viruses A and B: two new members of the Flaviviridae associated with GB agent hepatitis. J Virol 1995; 69: 5621-5630.
5. [5] Schlauder GG, Dawson GJ, Simons JN, et al. Molecular and serologic analysis in the transmission of the GB hepatitis agents. J Med Virol 1995; 46: 81-90.
6. [6] Simons JN, Leary TP, Dawson GJ, et al. Isolation of novel virus-like sequences associated with human hepatitis. Nature Med 1995; 1: 564-569.
7. [7] Leary TP, Muerhoff AS, Simons JN, et al. Sequence and genomic organization of GBV-C: a novel member of the Flaviviridae associated with human non-A-E hepatitis. J Med Virol 1996; 48: 60-67.
8. [8] Gimson AES, O'Grady J, Ede RJ, et al. Late onset hepatic failure: clinical, serological and histological features. Hepatology 1986; 6: 288-294.
9. [9] Yoshiba M, Okamoto H, Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology. Lancet 1995; 346: 1131-1132.
10. [10] Tillmann H, Trautwein C, Walker D, et al. Clinical relevance of mutations in the precore genome of the hepatitis B virus. Gut 1995; 37: 568-573.
11. [11] Japanese Red Cross Non-A, Non-B Hepatitis Research Group. Effect of screening for hepatitis C virus antibody and hepatitis B virus core antibody on incidence of post-transfusion hepatitis. Lancet 1991; 338: 1040-1041.
12. [12] Gimson AES, White YS, Eddleston ALWF, et al. Clinical and prognostic differences in fulminant hepatitis type A, B, and non-A non-B. Gut 1983; 24: 1194-1198.
13. [13] Sato S, Suzuki K, Akahane Y, et al. Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis. Ann Intern Med 1995; 122: 241-248.